An Act to Simplify Regulation of the Adult Use Cannabis Industry
Maine Legislature, Session 132, LD 1820
Committee: Veterans and Legal Affairs
Sponsors: CHAPMAN
Amends: 28-B MRSA §106, 28-B MRSA §115, 28-B MRSA §204, 28-B MRSA §213, 28-B MRSA §502, 28-B MRSA §504, 28-B MRSA §504-A, 28-B MRSA §505, 28-B MRSA §507, 28-B MRSA §510, 28-B MRSA §512, 28-B MRSA §701, 28-B MRSA §702, 28-B MRSA §802-A, 28-B MRSA §1501, 36 MRSA §4921, 36 MRSA §4923

Legislative Document
No. 1820
H.P. 1218
House of Representatives, April 29, 2025
An Act to Simplify Regulation of the Adult Use Cannabis Industry
Reference to the Committee on Veterans and Legal Affairs suggested and ordered printed.
ROBERT B. HUNT
Clerk
Presented by Representative CHAPMAN of Auburn.
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  28-B MRSA §106, as amended by PL 2023, c. 679, Pt. B, §14, is repealed.
Sec. 2.  28-B MRSA §115 is enacted to read:
§115.  Forms; waiver of rights
The office may not require a licensee to sign a form or agreement developed by the 
office that waives the licensee's rights regarding the release of information that would 
otherwise be protected from disclosure by any constitutional, statutory or common law 
privilege.
Sec. 3.  28-B MRSA §204, sub-§6, as amended by PL 2023, c. 679, Pt. B, §30, is 
further amended to read:
6.  Use of criminal history record information.  State and national criminal history 
record information obtained by the office under this section may be used only for the 
purpose of screening an applicant for a license or a licensee under this chapter or as 
necessary for the issuance of an individual identification card under section 106.
Sec. 4.  28-B MRSA §213, as amended by PL 2023, c. 679, Pt. B, §45, is further 
amended to read:
§213.  Notice of new principal
Before any proposed new principal may own, manage, work for or otherwise associate 
with a licensee, the licensee shall notify the office in writing of the name, address and date 
of birth of the proposed new principal.  The proposed new principal shall submit to a 
criminal history record check pursuant to section 204, obtain an individual identification 
card pursuant to section 106 and, in the case of a new principal or other person assuming 
an equity ownership interest or a partial equity ownership interest in the license, obtain 
approval for the transfer of ownership interests pursuant to section 210, unless the transfer 
of ownership interests is otherwise exempt from prior approval under section 210, 
subsection 1-A.
Sec. 5.  28-B MRSA §502, sub-§1-A, as enacted by PL 2023, c. 679, Pt. B, §68, is 
amended to read:
1-A.  Manufacture of products not containing cannabis.  Notwithstanding 
subsection 1, a products manufacturing facility licensee that also has a license issued from 
the Department of Agriculture, Conservation and Forestry pursuant to subsection 10 may 
manufacture for sale or distribution any products that the facility is authorized to 
manufacture or distribute pursuant to the provisions of that license, including products that 
do not contain cannabis, except that a products manufacturing facility licensee is prohibited 
from extracting hemp as defined in Title 7, section 2231, subsection 1‑A, paragraph D or 
manufacturing products that contain hemp or ingredients derived from hemp that do not 
also contain cannabis.  Nothing in this This subsection may not be construed to prohibit a 
products manufacturing facility licensee from using ingredients derived from hemp in the 
manufacture of cannabis products.  
A.  A products manufacturing facility licensee that manufactures adult use cannabis 
and adult use cannabis products within the same facility in which the licensee also 
manufactures products that do not contain cannabis must comply with all applicable 
requirements of this chapter and the rules adopted pursuant to this chapter concerning 
the operation of products manufacturing facilities.
B.  The following items or areas within the facility may be shared for both the 
manufacturing of adult use cannabis and adult use cannabis products and the 
manufacturing of products that do not contain cannabis:
(1)  Manufacturing-related and nonmanufacturing-related equipment and supplies, 
except that manufacturing-related equipment and supplies may not be 
simultaneously used for the manufacturing of adult use cannabis and adult use 
cannabis products and the manufacturing of products that do not contain cannabis;
(2)  Manufacturing-related and nonmanufacturing-related supplies or products that 
do not contain cannabis or cannabis products and the storage areas for those 
supplies or products; and
(3)  General office space, bathrooms, entryways and walkways.
C.  A products manufacturing facility licensee must ensure that:
(1)  Manufacturing-related equipment and supplies are not simultaneously used for 
the manufacturing of cannabis and cannabis products and the manufacturing of 
products that do not contain cannabis;
(2)  Manufacturing-related equipment is sanitized between the manufacturing of 
cannabis and cannabis products and the manufacturing of products that do not 
contain cannabis;
(3)  Cannabis and cannabis products are kept separate from products that do not 
contain cannabis;
(4)  Cannabis and cannabis products are packaged and labeled accurately pursuant 
to the requirements of this chapter and the rules adopted pursuant to this chapter; 
and
(5)  Products that do not contain cannabis are packaged and labeled accurately 
pursuant to the provisions of the license issued by another department to 
manufacture products that do not contain cannabis; and.
(6)  Any person manufacturing products that do not contain cannabis in a licensed 
manufacturing facility obtains an individual identification card from the office 
pursuant to section 106, except that the person is not required to submit to a 
criminal history record check.
Sec. 6.  28-B MRSA §504, sub-§9, ¶D is enacted to read:
D.  The office may not adopt a rule that requires a cannabis store, cultivation facility 
or products manufacturing facility to video record all transactions conducted through 
a delivery service pursuant to this subsection.
Sec. 7.  28-B MRSA §504, sub-§9, ¶E is enacted to read:
E.  The office shall adopt rules allowing a cannabis store, cultivation facility or 
products manufacturing facility that operates a delivery service pursuant to this 
subsection to record delivery transactions through the tracking system implemented 
pursuant to section 105.
Sec. 8.  28-B MRSA §504, sub-§12, as enacted by PL 2023, c. 679, Pt. B, §94, is 
amended by amending the first blocked paragraph to read:
A cannabis store shall package and label samples in accordance with the applicable 
provisions of this chapter and the rules adopted pursuant to this chapter. A cannabis store 
may not provide samples to a person who is visibly intoxicated.  The total amount of 
samples, adult use cannabis and adult use cannabis products given or sold to a person in 
any one 24-hour period may not exceed the maximum amount of adult use cannabis or 
adult use cannabis products allowed under section 1501, subsection 1, paragraph F.
Sec. 9.  28-B MRSA §504-A, sub-§4, ¶E, as amended by PL 2023, c. 679, Pt. B, 
§100, is repealed.
Sec. 10.  28-B MRSA §504-A, sub-§8 is enacted to read:
8.  Tracking system.  The office shall adopt rules allowing sales of adult use cannabis 
and adult use cannabis products under a specified event permit to be recorded through the 
tracking system implemented pursuant to section 105.  Adult use cannabis and adult use 
cannabis products offered for sale at a specified event and the location of the specified 
event must be recorded in the system pursuant to the rules adopted under this subsection.
Sec. 11.  28-B MRSA §505, as amended by PL 2023, c. 679, Pt. B, §103, is further 
amended by enacting at the end a new paragraph to read:
The office shall establish a generic transport manifest for deliveries made pursuant to 
this section to be provided to a law enforcement officer in the case of a traffic stop or other 
relevant event.  The generic transport manifest may not require the recording of customer 
data or tracking identification of the products being transported.
Sec. 12.  28-B MRSA §507, as repealed and replaced by PL 2023, c. 679, Pt. B, 
§105, is amended to read:
§507.  Entry into cannabis establishment by minors
A minor may not enter the licensed premises of a cannabis store unless accompanied 
by the minor's parent, legal guardian or custodian, as defined in Title 22, section 4002, 
subsection 5.  An individual identification card holder who is the parent, legal guardian or 
custodian of a minor may bring that minor into the licensed premises of a cultivation 
facility, products manufacturing facility or cannabis testing facility in an emergency.
Sec. 13.  28-B MRSA §510, as amended by PL 2023, c. 679, Pt. B, §108, is further 
amended to read:
§510.  Limited access areas
Except as provided in subsection 1, a person may not enter or remain in any limited 
access area unless the person displays an individual identification card issued by the office 
pursuant to section 106.
1.  Contractors.  A licensee may allow a person to enter or remain in any limited 
access area without displaying an individual identification card if the person is a contractor 
of the licensee, including, but not limited to, an electrician, a plumber, an engineer or an 
alarm technician, whose scope of work will not involve the handling of cannabis or 
cannabis products and the person signs a visitor entry log provided and maintained by the 
licensee and is issued a visitor identification badge by the licensee.
1-A.  Visitors.  A licensee may allow a visitor who is not a minor to enter or remain in 
any limited access area without displaying an individual identification card if the visitor 
signs a visitor entry log provided and maintained by the licensee, the visitor is issued a 
visitor identification badge by the licensee and, if the visitor is visiting in a limited access 
area with immediate access to cannabis or cannabis products, the visitor is accompanied at 
all times by the licensee or an employee of the licensee.
2.  Licensee compliance Conspicuously marked.  A licensee shall ensure that all 
areas of ingress to and egress from limited access areas within its licensed premises are 
conspicuously marked and that a person is not allowed to enter or remain in any limited 
access area without displaying the person's individual identification card issued by the 
office pursuant to section 106.
Sec. 14.  28-B MRSA §512, as amended by PL 2023, c. 679, Pt. B, §110, is further 
amended by amending the section headnote to read:
§512.  Inspection of licensed premises; testing Testing and sampling for product 
quality control
Sec. 15.  28-B MRSA §512, sub-§1, as amended by PL 2023, c. 679, Pt. B, §110, 
is repealed.
Sec. 16.  28-B MRSA §701, sub-§1, ¶J, as amended by PL 2023, c. 679, Pt. B, 
§122, is further amended by amending subparagraph (3) to read:
(3)  A recommended use date or expiration date; and
Sec. 17.  28-B MRSA §701, sub-§1, ¶K, as enacted by PL 2017, c. 409, Pt. A, §6 
and amended by PL 2021, c. 669, §5, is further amended to read:
K.  For edible cannabis products, a nutritional fact panel; and.
Sec. 18.  28-B MRSA §701, sub-§1, ¶L, as amended by PL 2023, c. 679, Pt. B, 
§122, is repealed.
Sec. 19.  28-B MRSA §702, sub-§2, ¶A, as enacted by PL 2017, c. 409, Pt. A, §6 
and amended by PL 2021, c. 669, §5, is further amended to read:
A.  A prohibition on health or physical benefit claims in advertising or marketing, 
including, but not limited to, health or physical benefit claims on the label or packaging 
of adult use cannabis or an adult use cannabis product, except that advertising, 
marketing, labeling or packaging may contain qualifying patients' testimonials of how 
cannabis for medical use has provided palliative or therapeutic effects for the patients' 
conditions.  All testimonials must contain the following disclaimer: "This statement 
has not been evaluated by the United States Food and Drug Administration. This 
product is not intended to diagnose, treat, cure or prevent any disease.";
Sec. 20.  28-B MRSA §802-A, sub-§2, ¶A, as enacted by PL 2023, c. 679, Pt. B, 
§134, is amended by repealing subparagraph (6).
Sec. 21.  28-B MRSA §802-A, sub-§2, ¶C, as enacted by PL 2023, c. 679, Pt. B, 
§134, is amended by repealing subparagraph (7).
Sec. 22.  28-B MRSA §802-A, sub-§2, ¶C, as enacted by PL 2023, c. 679, Pt. B, 
§134, is amended by repealing subparagraph (9).
Sec. 23.  28-B MRSA §1501, sub-§1, ¶D, as enacted by PL 2017, c. 409, Pt. A, §6 
and amended by PL 2021, c. 669, §5, is further amended to read:
D.  Transfer or furnish, without remuneration, to a person 21 years of age or older up 
to 6 immature cannabis plants or seedlings; and
Sec. 24.  28-B MRSA §1501, sub-§1, ¶E, as amended by PL 2023, c. 220, §1, is 
further amended to read:
E.  Subject to the requirements and restrictions of section 1502, possess, cultivate or 
transport at any one time up to 6 mature cannabis plants, 12 immature cannabis plants 
and an unlimited number of seedlings and possess all the cannabis produced by such 
plants at the person's place of residence or at the location where the cannabis was 
cultivated;.
Sec. 25.  28-B MRSA §1501, sub-§1, ¶F, as amended by PL 2023, c. 396, §22, is 
repealed.
Sec. 26.  28-B MRSA §1501, sub-§1, ¶G, as enacted by PL 2017, c. 409, Pt. A, 
§6 and amended by PL 2021, c. 669, §5, is repealed.
Sec. 27.  36 MRSA §4921, sub-§4-A is enacted to read:
4-A.  Cannabis biomass.  "Cannabis biomass" means any part of a cannabis plant, 
whether processed or unprocessed, including dried cannabis flower or cannabis seeds, used 
for extraction and manufactured into concentrate, except that "cannabis biomass" does not 
include the stalks or roots of the cannabis plant.  "Cannabis biomass" does not include any 
part of a hemp plant as described in Title 7, section 2231, subsection 1-A, paragraph D.
Sec. 28.  36 MRSA §4923, sub-§2, as enacted by PL 2019, c. 231, Pt. B, §7 and 
amended by PL 2021, c. 669, §5, is further amended to read:
2.  Excise tax on cannabis trim and biomass.   A cultivation facility licensee shall 
pay an excise tax of $94 per pound or fraction thereof of cannabis trim or biomass sold to 
other licensees in the State.
SUMMARY
This bill amends the Cannabis Legalization Act and the laws governing personal adult 
use of cannabis by eliminating the individual identification card requirement for licensees, 
eliminating cannabis purchase limits, eliminating certain requirements regarding the 
inspection of licensed premises and eliminating certain cannabis and cannabis product 
labeling requirements.  The bill amends certain provisions regarding cannabis delivery 
transactions, including allowing licensees to use the tracking system established by the 
Department of Administrative and Financial Services, Office of Cannabis Policy to track 
delivery transactions and sales at specified events.  The bill prohibits the Office of Cannabis 
Policy from requiring licensees to sign forms that require the licensees to waive certain 
rights protected under constitutional, statutory or common law privilege.  The bill also 
clarifies excise tax laws as they apply to cannabis biomass.